According to Fortune Business Insights, the global diabetes drugs market was valued at USD 88.32 billion in 2024. The market is projected to grow from USD 101.48 billion in 2025 to USD 233.84 billion by 2032, exhibiting a CAGR of 12.7% during the forecast period. In 2024, North America dominated the diabetes drugs market with a market share of 49.95%.